DRREDDY's weekly performance was disappointing, with a return of -2.73% and a Sharpe Ratio of -2.35, indicating poor risk-adjusted returns. The stock's volatility was relatively low at 4.65%, but its max drawdown was also -2.73%, suggesting a lack of upside potential. Compared to its peers, DRREDDY outperformed HINDUNILVR but underperformed DIVISLAB and SUNPHARMA. Overall, the stock's risk profile was relatively low this week.

[Volatility: 4.65%]